Axogen (AXGN)

Axogen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AXGN

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
14/11/2024	20:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:AXGN	Axogen Inc
14/11/2024	20:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:AXGN	Axogen Inc
07/11/2024	21:34	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:AXGN	Axogen Inc
07/11/2024	21:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AXGN	Axogen Inc
07/11/2024	15:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
07/11/2024	12:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc
07/11/2024	12:00	GlobeNewswire Inc.	Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update	NASDAQ:AXGN	Axogen Inc
24/10/2024	11:00	GlobeNewswire Inc.	Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024	NASDAQ:AXGN	Axogen Inc
17/09/2024	20:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
13/09/2024	20:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
10/09/2024	20:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:AXGN	Axogen Inc
06/09/2024	11:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc
06/09/2024	11:00	GlobeNewswire Inc.	Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®	NASDAQ:AXGN	Axogen Inc
05/09/2024	20:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
05/09/2024	01:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
05/09/2024	01:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
05/09/2024	00:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
05/09/2024	00:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
04/09/2024	23:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
04/09/2024	21:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
03/09/2024	11:00	GlobeNewswire Inc.	Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)	NASDAQ:AXGN	Axogen Inc
21/08/2024	20:31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
13/08/2024	21:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
13/08/2024	20:18	GlobeNewswire Inc.	CytoSorbents Appoints Peter J. Mariani Chief Financial Officer	NASDAQ:AXGN	Axogen Inc
12/08/2024	14:59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
09/08/2024	20:36	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AXGN	Axogen Inc
09/08/2024	20:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
09/08/2024	20:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
09/08/2024	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc
08/08/2024	20:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AXGN	Axogen Inc